Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Exercise and Cancer Survival; COVID Vaccine and Immune Checkpoint Inhibitors

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El Paso, look at the top medical...

Exercise and Cancer Survival; COVID Vaccine and Immune Checkpoint Inhibitors

A recent meta-analysis of randomized controlled trials suggests that structured exercise after cancer treatment can improve overall survival, disease-free survival, and cancer-specific mortality. The study included nearly 8,500 participants, primarily women with breast cancer, and found a 23% benefit in overall survival, with similar improvements in disease-free survival and all-cause mortality.

The authors speculate that exercise may enhance the infiltration of cytotoxic T cells and natural killer cells into tumors, increase drug penetration, and reduce tumor glucose levels. However, the data did not consistently address progression-free survival or pathological complete response.

Written by urgent.news from MedPage Today's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Saturday 26 September →